MSICS Pharma

📍 Tel Aviv, Israel🗓 Founded 2020👥 5 employees💰 Last funded Mar 2024
MSICS Pharma is a pioneering company in the field of naturally-sourced Psilocybin production based in Israel. MSICS Pharma, operates under first-of-its-kind licenses from the Israeli Ministry of Health, allowing it to produce Psilocybin in its GMP facility. Through its groundbreaking studies in collaboration with renowned institutions, MSICS is actively involved in exploring the potential of Psilocybin in various medical indications. With its unique licenses, strong industry knowledge, and strategic partnerships, MSICS forms a solid foundation for success, enabling it to lead the way in the responsible and innovative use of Psilocybin.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in MSICS Pharma?
MSICS Pharma has 1 investors on record on gritt.io, 1 mid-stage.
When did MSICS Pharma last raise funding?
The most recent investment in MSICS Pharma recorded on gritt.io was in March 2024.
When was MSICS Pharma founded?
MSICS Pharma was founded in 2020.
What industry is MSICS Pharma in?
MSICS Pharma operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is MSICS Pharma based?
MSICS Pharma is headquartered in Tel Aviv, Israel.